Editha Renesteen | Microbiome | Best Researcher Award

Ms. Editha Renesteen | Microbiome | Best Researcher Award

Ms. Editha Renesteen at McGill University, Canada

Editha Renesteen is a PhD candidate in Biological & Biomedical Engineering at McGill University, supported by the prestigious LPDP scholarship. With an MSc in Medical Biotechnology from Wageningen University, she focuses on microbiome research and Alzheimer’s disease 🧠. Editha has authored impactful publications, led COVID-19 testing efforts, and guided students in publishing their own research. As a lecturer and project leader, she achieved ISO and national accreditation milestones 🏅. Her achievements in global hackathons, science communication, and academic leadership make her a passionate and inspiring emerging researcher.📚🌍🎥

Publication Profile📚

Orcid

Scopus

Google Scholar

Academic Background🎓

Editha Renesteen is a dedicated PhD candidate in Biological & Biomedical Engineering at McGill University, supported by the prestigious LPDP scholarship. She holds an MSc in Medical Biotechnology from Wageningen University , where she gained expertise in advanced biotechnological research 🧬. Her academic journey began with a Bachelor’s degree in Pharmacy and a Pharmacist certification from Universitas Indonesia. Throughout her education, Editha has demonstrated excellence in research, presenting at international conferences 🌍 and publishing scientific papers 📚. Her strong educational foundation continues to fuel her impactful work in microbiome science and Alzheimer’s disease research 🧠.

Professional Experience💼

Editha Renesteen has built a diverse and impactful professional career in academia and research 🌟. Currently a PhD candidate at McGill University, she leads research on microbiome and Alzheimer’s disease 🧠. She previously served as a lecturer at the Republic of Indonesia Defense University and Swiss German University, mentoring students to publish scientific papers 📄. As a research assistant at IMERI-FKUI, she played a key role in nationwide COVID-19 RT-PCR testing 🧪. Editha has also led projects achieving ISO 21001:2018 certification 🏅 and national academic accreditation, showcasing her leadership in both scientific and educational excellence 🌍.

Awards and Honors🏅

Editha Renesteen has received numerous prestigious awards in recognition of her academic excellence and leadership. She is a two-time recipient of the Indonesia Endowment Fund for Education (LPDP) scholarship, supporting both her MSc and PhD studies. In 2024, she won second place in HackMedTech Canada 🧠, an innovation hackathon tackling real-world medical challenges. She was also selected as one of only 25 global participants in the 2023 DAAD UNILEAD program in Germany, focusing on academic leadership and project management. These honors reflect her commitment to impactful research, innovation, and global collaboration🎓🌟🌍.

Research Focus🔬

Editha Renesteen’s research is centered on the intersection of microbiome science and neurodegenerative diseases 🧠, with a special focus on Alzheimer’s disease. As a PhD candidate at McGill University, she explores how gut–brain axis modulation can lead to innovative biotherapeutics 🌿. Her work integrates molecular biology, microbiome engineering 🧬, and biomedical innovation to uncover novel treatment pathways. With several publications in high-impact journals 📚, Editha also contributes to studies on infectious diseases, including HIV, tuberculosis, and COVID-19 🦠. Her multidisciplinary approach and commitment to translational science drive meaningful progress in global health research 🌍.

Publication Top Notes📄

Microbiome Engineering for Biotherapeutic in Alzheimer’s Disease Through the Gut–Brain Axis
Year: 2025 | Cited by: 2 📑

Select Probiotics Exhibit Antioxidative and Anti-Inflammatory Properties for Gut Modulation: In Vitro Analysis
Year: 2024 | Cited by: 4 📑

Baculovirus Expressing Tumor Growth Factor-β1 Nanoshuttle Augments Therapeutic Effects for Vascular Wound Healing
Year: 2024 | Cited by: 3 📑

The Regenerative Potential of Pax3/Pax7 on Skeletal Muscle Injury
Year: 2022 | Cited by: 5 📑

Recent Advances in the Diagnosis of Intestinal Tuberculosis
Year: 2022 | Cited by: 8 📑

Conclusion🌟

In conclusion, Editha Renesteen stands out as an exceptional candidate for the Best Researcher Award, particularly in the emerging researcher category. With a robust academic background including a PhD in progress at McGill University and an MSc from Wageningen University, she has demonstrated excellence in interdisciplinary research on the microbiome and Alzheimer’s disease. Her impactful publications in high-ranking journals, leadership in academic accreditation and ISO certification, and hands-on role in national COVID-19 efforts reflect her dedication to advancing science and public health. Recognized internationally through awards like HackMedTech and DAAD UNILEAD, Editha exemplifies innovation, leadership, and global research impact.